Reactive Infectious Mucocutaneous Eruption ( RIME ): An Australian Case Series

Australasian Journal of Dermatology 2026 Open access

Read full text
Authors: Hamish Moore, Emma Ryan, Annabel Stevenson
DOI: 10.1111/ajd.70068
Cited by: 0
References: 6

Abstract

Whilst Reactive Infectious Mucocutaneous Eruption (RIME) displays a low mortality rate, the condition results in significant morbidity and resource allocation, including prolonged hospital admission. As such, early diagnosis and optimisation of treatment is imperative. A retrospective review of paediatric patients in South Australia suffering with RIME across 2023 and 2024 was conducted, analysing trends in aetiology, diagnosis, management and long-term outcomes. Our findings emphasise the need for early input from a specialist paediatric dermatologist and highlight the need for vigilance during times of Mycoplasma pneumoniae outbreak.

Fields of Study & Subjects

Dermatological and COVID-19 studies Dermatological diseases and infestations Herpesvirus Infections and Treatments

Publication details

Journal / source
Australasian Journal of Dermatology
Volume
67
Issue
4
Pages
241–246
Publication date
16 February 2026
Language
EN